← Back to Search

Cannabis Effects for Elder Care Services

Phase 1
Waitlist Available
Led By Alison Oliveto, PhD
Research Sponsored by University of Arkansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-drug and 1, 2, 3, and 5.5 hours post-drug administration
Awards & highlights

Study Summary

This trial studied how marijuana affects mood, thinking, movement, balance, and heart rate in older people.

Who is the study for?
This trial is for older adults who have not used psychoactive drugs, tobacco, or cannabis recently. They must be in stable health with controlled medical conditions and no history of serious substance abuse or cognitive disorders. Women must be post-menopausal or not capable of bearing children.Check my eligibility
What is being tested?
The study tests the effects of up to three doses of cannabis on mood, cognition, psychomotor performance, balance, and vital signs in older adults to understand how it affects them differently than younger populations.See study design
What are the potential side effects?
Potential side effects from cannabis use may include changes in mood and perception, dizziness or balance issues, altered cognitive function and psychomotor performance which could affect tasks like driving.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-drug and 1, 2, 3, and 5.5 hours post-drug administration
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-drug and 1, 2, 3, and 5.5 hours post-drug administration for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Balance Tests - 30 sec chair-stand
Balance Tests - Four-Stage
Balance Tests - Timed Up and Go
+8 more
Secondary outcome measures
Cognitive Function Tests - Auditory learning
Cognitive Function Tests - Card Sort
Cognitive Function Tests - Flanker
+6 more
Other outcome measures
Acceptability - AEs
Acceptability - duration of assessments
Acceptability - food
+6 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Cannabis (up to three doses)Experimental Treatment1 Intervention
Brownies containing a dose of cannabis

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

University of ArkansasLead Sponsor
486 Previous Clinical Trials
150,348 Total Patients Enrolled
Alison Oliveto, PhDPrincipal InvestigatorUniversity of Arkansas
8 Previous Clinical Trials
488 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research project permit seniors to participate?

"This clinical trial is accepting participants aged between 55 and 70 years old."

Answered by AI

Is it possible to join the research cohort for this experiment?

"The criteria for acceptance into this trial necessitates that the participants have access to senior services and are between 55-70 years old. This investigation seeks to find 5 suitable candidates."

Answered by AI

What is the potential risk associated with using Cannabis in up to three doses?

"Our assessment of cannabis' safety (with a maximum three dose) was rated at 1 due to the restricted amount of available data on its efficacy and safety."

Answered by AI

Is enrollment currently occurring for this research project?

"Data posted on clinicaltrials.gov affirms that this trial is not presently accepting patients; however, the study was initially published October 1st 2023 and last amended September 19th 2023. Fortunately, 92 other studies are actively recruiting candidates right now."

Answered by AI

What are the fundamental aims of this experiment?

"The primary endpoint of this clinical trial is a measure of vitals signs - respiration, which will be assessed over the pre-drug and 1, 2, 3, & 5.5 post-administration time frames. Secondary endpoints include cognitive function tests such as Picture Sequence Memory (participants reproducing sequences of pictures), List Sorting Working Memory (a sequencing task) and Picture Vocabulary Tests to evaluate English language comprehension abilities in adults."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Behavioral Pharmacology of Cannabis in Older Adults
2024. "Behavioral Pharmacology of Cannabis in Older Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06055309.
~3 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top